Back to 
Avoro Capital Advisors LLC
Avoro Capital Advisors LLC
KPTI
Showing 0 of 6 quarters
Position history for Avoro Capital Advisors LLC's holdings in Karyopharm Therapeutics Inc.
No. Avoro Capital Advisors exited its KPTI (Karyopharm Therapeutics) position in Q4 2020. Its Q3 2020 13F listed 6,000,000 shares worth $87.6M. Avoro Capital Advisors first reported KPTI in Q3 2019 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.